Skip to content
OpenCapital
Get started

Medtronic MDT Cardiovascular — Net Sales

Other segment segments

Neuroscience
$2.75B+5.0%
Medical Surgical
$2.39B+8.0%
Diabetes
$838M+15.1%
Other Operating Segments
$135M—
Other operating segment
$32M0.0%

Similar metrics at other companies

Boston Scientific logo
BSXCardiovascular — Net sales of reportable segments
$3.5B+10.9%
Boston Scientific logo
BSXCardiovascular — Other segment items, percentage of net sale
0.2%0.0pp
Boston Scientific logo
BSXCardiovascular — Cost of products sold, percentage of net sale
30.5%+1.2pp
Boston Scientific logo
BSXCardiovascular — Selling, general and administrative expenses, percentage of net sale
27.4%-0.3pp
Boston Scientific logo
BSXCardiovascular — Cost of products sold
$1.07B+15.2%
Boston Scientific logo
BSXCardiovascular — Segment operating income, percentage of net sale
32.1%-1.7pp

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$101.86B-3.8%
Enterprise value$129.12B-3.2%
P/E21.2×-1.5×
P/S2.8×-0.4×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's cardiovascular — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's cardiovascular — net sales?
Medtronic (MDT) reported cardiovascular — net sales of $3.8B in Q1 2026.
How has Medtronic's cardiovascular — net sales changed year-over-year?
Medtronic's cardiovascular — net sales increased by 13.8% year-over-year, from $3.34B to $3.8B.
What is the long-term trend for Medtronic's cardiovascular — net sales?
Over 5 years (2021 to 2026), Medtronic's cardiovascular — net sales has grown at a 5.3% compound annual growth rate (CAGR), from $10.77B to $13.98B.
What does cardiovascular — net sales mean?
The total revenue earned from selling cardiovascular medical devices.
How do you interpret cardiovascular — net sales?
Higher sales indicate strong market adoption, successful product launches, or effective sales execution.
How does cardiovascular — net sales compare across companies?
Comparable to net revenue reported for cardiovascular business units at major medical device peers.